State Atomic Energy Corporation Rosatom Russian Radiation Technologies: opportunities to success

Similar documents
Nuclear medicine and Radiation technologies

Isotope Production for Nuclear Medicine

PANEL DISCUSSION. Radionuclides and Health A promising future! OCTOBER 14-16, 2014 PARIS LE BOURGET FRANCE

AEPHY: Nuclear Physics Practise Test

The Production of Medical Isotopes. CAND meets TPU

Isotope Production from Compact Neutron Sources. ~ 10 6 n/sec. Danish CANS workshop Mikael Jensen

Center for Design and Synthesis of Radiopharmaceuticals for Molecular Targeting CERAD on the Polish Roadmap for Research Infrastructures

Best MeV. Best , 25 MeV

Radiopharmaceuticals for Nuclear Medicine and Oncology The Central Role of Chemistry

Section 3: Nuclear Radiation Today

METHODS of RADIONUCLIDE PRODUCTION for MEDICAL ISOTOPE USABILITY

THE IAEA COLLABORATING CENTRE FOR NEUTRON ACTIVATION BASED METHODOLOGIES OF RESEARCH REACTORS

CLINICALLY USEFUL RADIONUCLIDES:

Institute of Isotopes Co., Ltd.

MECHANICAL ENGINEERING. Five-year M.Sc. studies School of Mechanical Engineering National Technical University of Athens

DIVA: THE DUTCH ISOTOPE VALLEY ABSTRACT

Testimony. Before the Subcommittee on Environment, Energy, and Natural Resources, Committee on Government Operations House of Representatives

RUSSIAN CHEMICAL INDUSTRY

Radiotracers for Early Diagnosis - ReSearching for a Better Life!

III. Proton-therapytherapy. Rome SB - 2/5 1

PRODUCTION OF RADIOISOTOPES FOR IMAGING AND THERAPY AT LOW ENERGY

The use of high-flux reactor SM-3 for activation process of molibdenum-99 production

6. Radioactive Sources and IAEA Course Catalog

TRIUMF TR13. Date form last updated: 2016 May 29. Completed by: David Prevost. 1. Cyclotron Facility Contact info. Institute (name/address):

RPR 29 CYCLOTRON RADIOCHEMISTRY LABORATORY

Nuclear Chemistry. Background Radiation. Three-fourths of all exposure to radiation comes from background radiation.

International Workshop PSD-11 Delft. Clive Naidoo (PhD Chemistry) Dept Head: Radionuclide Production ithemba LABS South Africa

Revision checklist. Step Learning outcome Had a look Nearly there Nailed it!

Radiochemistry and Radiopharmacy III

about GCC

Global Coal Bed Methane (CBM) Market Professional Survey Report 2016

European Lignite Mines Benchmarking. Sanitized Report

The isotope revolution that can change imaging and therapy

NUCLEAR SCIENCE & ENGINEERING (NSE)

RECH-1 RESEARCH REACTOR: PRESENT AND FUTURE APPLICATIONS

Applications for Industry and Environment. Radioisotope and Radiation Technology. International Atomic Energy Agency

Major Nuclear and Radiation Physics experimental facilities in. Prepared By Dr M Tanseer Ali

Nuclear Medicine Treatments and Clinical Applications

Low Energy Medical Isotope Production. Naomi Ratcliffe IIAA, University of Huddersfield UK

The Comprehensive Report

REVIEW OF COMPACT COMMERCIAL ACCELERATOR PRODUCTS AND APPLICATIONS

Nuclear Physics and Astrophysics

List of Legislative Regulations Dealing with Nuclear Energy and Ionizing Radiation and Related Documents

SODIUM PERTECHNETATE ( 99m Tc) INJECTION (FISSION): Revised Final text for addition to The International Pharmacopoeia (January September 2009)

Introduction... vii ACC Economics and Statistics Department Staff... vii 1. CHEMISTRY AND THE ECONOMY...1

Nuclear Medicine RADIOPHARMACEUTICAL CHEMISTRY

For Excellence in Organic Chemistry

MEDICAL RADIOISOTOPE PRODUCTION IN RESEARCH REACTORS

Unit 12: Nuclear Chemistry

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS

Applied Nuclear Physics at the NUS Physics Department

Radioactive Waste Characterization and Management Post-Assessment Answer Key Page 1 of 7

Medical Applications of Nuclear Radiation and Isotopes

Questions. 1. What kind of radiation dominates the first phase of radiation emission from a nuclear fireball?

Intermediates. THF Solutions. Expanded Tetrahydrofuran Offer for Pharma Customers in Europe

Overview and Status of the Austrian Particle Therapy Facility MedAustron. Peter Urschütz

Nuclear Reactions. Nuclear Reactions

DRAFT PROGRAM Registration of participants, welcome coffee, exhibition tour

NSAC Isotopes Subcommittee Meeting January 20, 2015 Erin Grady, MD Society of Nuclear Medicine and Molecular Imaging

Positron Emission Tomography Dr. William C. Uhland Tyco-Mallinckrodt Pharmaceuticals, Maryland Heights, Missouri, USA

Draft Model Memorandum of Understanding to promote voluntary cooperation between Government and Chemical Industry to enhance Precursors Chemicals

Lecture PowerPoints. Chapter 31 Physics: Principles with Applications, 7th edition Giancoli

Project of RIC-80 facility at PNPI for medical isotope production

Radioisotopes and PET

Differentiating Chemical Reactions from Nuclear Reactions

Design and production of Scintillation Detectors

Global and China Sodium Silicate Industry 2014 Market Research Report

SUPPORTING A THRIVING UK LIFE SCIENCES ECOSYSTEM

more ?Learning about plutonium

Received: 7 April 2014; accepted: 20 May wasn t foreseen at the territory of Ukraine at all.

Chapter 10. Section 10.1 What is Radioactivity?

Advancing Geoscientific Capability. Geological Survey of Finland

SOLIDS EUROPEAN SERIES SOLIDS BASEL November 2016 Messe Basel. Trade show for granules, powder & bulk solids technologies.

12/1/17 OUTLINE KEY POINTS ELEMENTS WITH UNSTABLE NUCLEI Radioisotopes and Nuclear Reactions 16.2 Biological Effects of Nuclear Radiation

Mohamed BEN ABDALLAH

LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator

1. INTRODUCTION 2. EAEA EXISTING CAPABILITIES AND FACILITIES

INSTITUTE OF ISOTOPES CO. LTD. THE LEGACY OF A HUNGARIAN NOBEL PRIZE LAUREATE IN THE SERVICE OF LIFE AND MEDICINE

Radionuclide Production with Cyclotrons 2.0 Proposal for a CHERNE Summer School

The Green. Chemistry Checklist Why Green Chemistry? The Business Case. Inside. Support and Communication. Design and Innovation

Consider a. Collaboration. Do More with MURR. University of Missouri Research Reactor Center

Food Safety and Quality Management System

Key Question: What role did the study of radioactivity play in learning more about atoms?

C2-05: Creation of national standards for some emerging pharmaceutical radionuclides to ensure the radioprotection of patients and medical staffs

Lanceringsevent Smart Hub Vlaams-Brabant Brussels Airport optimaliseren door in te zetten op digitalisering en technologie

Russia region - Overview on chemical control legislation (labelling, MSDS, existing and new substances, etc) and aspects of GHS

KIVI 9 Oct 2015 Fysische Beeldtechnieken 18 feb

EPFL SB - 2/4 1

Services in Chemistry for a Sustainable World

Portable neutron generators of VNIIA and their applications

June 19 Huntsville, Alabama 1

NUCLEAR PHYSICS FOR MEDICINE. How nuclear research is improving human health

Radioisotopes in action. Diagnostic application of radioisotopes. Steps of diagnostic procedure. Information from various medical imaging techniques

NUCLEAR ENERGY! DAY 1: (RADIATION, FISSION, FUSION)

Nuclear Reactions. Nuclear Reactions

VOLAT TODAY AND TOMORROW

PHYSICOCHEMICAL CHARACTERISTICS OF URANIUM MICROPARTICLES COLLECTED AT NUCLEAR FUEL CYCLE PLANTS. Abstract

Lecture Presentation. Chapter 21. Nuclear Chemistry. James F. Kirby Quinnipiac University Hamden, CT Pearson Education, Inc.

Information Bulletin 5/2007

Power Installations based on Activated Nuclear Reactions of Fission and Synthesis

Transcription:

State Atomic Energy Corporation Rosatom Russian Radiation Technologies: opportunities to success M.Batkov, Director Radiation Technologies Program 15.04.2013

Rosatom is the largest hi-tech manufacturer in Russia 79,3% $15,5 bln* High-tech products share in revenue Revenue $700 mln R&D investment $5,2 bln* EBITDA * 2011 Rosatom annual report, currency rate 30.8 RUR/$ 2

Rosatom overview Nuclear Icebreakers Nuclear and Radiation Safety Applied and basic science Nuclear energy complex Nuclear Weapons Complex Civil Nuclear Applications Radiation Technologies Program ROSATOM is the largest utility in Russia which produces more than 40 % of electricity in the country; ROSATOM holds leading positions in the world market of nuclear technologies; 1-st in the world simultaneous nuclear build abroad; 2-nd in uranium reserves and 5-th in uranium mining; 4-th in nuclear electricity generation, Providing 40% of the world uranium enrichment services and 17% of the world nuclear fuel market Global operations in more than 40 countries 3

«Radiation Technologies» Program Subsidiaries Business activities Nuclear medicine Irradiation centers Waste management Sales of isotope products Sales of equipment Service Sales of isotope products on foreign markets (subsidiary company of JSC Isotope ) 4

Key projects of Radiation Technologies Program A number of interrelated innovative projects in the nuclear medicine field Origination and execution of investment projects in fields of medical isotopes and equipment Medical equipment sales and servicing R&D management Nuclear medicine Waste management First complex system of medical waste neutralization in Russia Irradiation centers 3D project of the most effective center for cold sterilization and modification of materials in the world Contract irradiation Equipment production, engineering and maintenance Production of radiation modified materials 5

Nuclear medicine

Russia has a lot of potential to develop. 1. Nowadays Russia have lack of nuclear medicine equipment in comparison with other countries. For example, there are only 1 SPECT and 0,1 PET/CT for 1 million people in Russia. 2. According to the "The development of healthcare in Russia" program the 251 units of SPECT, 251 units of SPECT/CT and 20 units of PET/CT equipment will be purchased during the period 2014-2018. 70 60 50 40 30 20 10 0 57 51 53 47 43 57 53 43 47 51 18 0 2 0 0 2014 2015 2016 2017 2018 SPECT SPECT/CT PET/CT 251 20 251 SPECT SPECT/CT PET/CT The purchasing of nuclear medicine equipment according to the program "The development of healthcare in Russia" from 2014 to 2018.. 3. Ministry of Economic Development of the Russian Federation has introduced a 15% preference for medical equipment produced in Russia which will be purchased by government. 4. According to "The development of pharmaceutical and medical industries in Russia till 2020 and beyond" the federal program, Ministry of Industry and Trade of Russia will introduce the protection measures for the equipment manufactured domestically. 7

In the Nuclear medicine field we perform the following functions 1. Investment projects execution in the fields of medical isotopes, equipment production, etc. 2. Sales of medical equipment and complex solution. 3. R&D management in nuclear medicine. 4. Collaboration with Russian state and international organizations on the nuclear medicine issues. 8

Processing factories producing radiopharmaceuticals Partner Engineering Construction Equipping Start in operation Export of Мо-99 Radiopharmaceuticals Mo99 Manufacturing Activation method (natural and/or enriched molybdenum) Fission-fragments method (fission product of Uranium) Production of radiopharmaceuticals and/or medical devices Sorption method Generator Мо-99/Тс-99 Extraction method Production Тс-99 Radiopharmaceuticals Radionuclide diagnostic department of medical center Ready to operate RPH manufacturing facility. 9

Nuclear medicine. Diagnostics and therapy. In 2014 ROSATOM becomes the manufacturer of most advanced equipment for nuclear medicine with a leading position in CIS markets! In 2014 ROSATOM constructs the the first national chain of PET-centers! In 2015 ROSATOM constructs the best in CIS center for nuclear medicine and cancer treatment. Manufacturing projects U.I. Corp. SPECT, PET, PET/CT Manufacturing JSC Isotope Compact cyclotrons Manufacturing JSC Isotope Ge/Ga Demand on equipment Equipment delivery Project «Construction of chain of diagnostic centers» Remuneration for referral of clients Referral of clients for treatment Project «Center for cancer treatment» JSC Isotope Proton therapy center 10

Mo99 Project results The project was set up in the shortest possible time 2.5 years. Hot testing on the first line has been conducted. Warm testing on the second line has been carried out. «Hot» cameras with manipulators Solvent installation Result: production facilities on 2000 Ki/week have been established. 11

RP and medical isotopes, 2012: Re-188 therapy centers 188Re-Lipiodol Promising radiopharmaceutical for the diagnosis of liver cancer and radiotherapy; Stable disease in 56% of cases; Partial response in 22% of cases; The absence of side effects (minimal effects in 93% of cases) Participants: The State Corporation ROSATOM WARMTH Seoul University Lipiodol Generator Re-188 12

R&D: the future comes today Construction of a SPECT scanner Diagnostic equipment Construction of a CT scanner Innovative equipment for radiochemical laboratory Medical cyclotrons different energies Reprocessing equipment Generator Ga-68/Ge-68 and synthesis facility New generation of cyclotron - СС12 Cancer treatment: radiopharmaceutical based on Ac-225 Radiopharmaceuticals Stages Market analysis Requirements specification Paperwork Selection of the Contractor R&D Engineering Selection of the work production space Engineering documentation Production start and license obtaining The sales channels are defined Start of sales 13

JSC Isotope

Global supplier for isotope products and solutions Global Distribution: 100 customers from over 30 countries 50 years of experience Officially represents 12 Facilities 360 product portfolio incl. Mo- 99, Tc-99m, Co-60 and stable isotopes Fission, Cyclotron, EM, GC Production capability Global logistics and nuclear safety expertise: over 1000 shipments per year 15

Medical isotopes JSC Isotope has a global expertise in timely supplying nuclear medicine products and solutions Our product portfolio includes key medical isotopes including: Mo-99 (Molybdenum-99) Tc-99m (Technetium-99m) I-125, 131 (Iodine- 125, 131) Lu-177 (Luecium-177) Gd-153 (Gadolinium-153) Ru-106 (Ruthenium-106) Pd-103 (Paladium-103) Ga-67 (Gallium-67 In-111 (Indium-111) Re-188 Applications: Diagnostics and therapy Cardiology Neurology Oncology Producers: 16

Range of medical equipment Equipment for diagnostic and therapeutic centers: PET/CT and SPECT/CT tomography scanners for nuclear medicine; Cyclotron complexes for radiopharmaceutical production; Laboratory complexes for Ga-68 radiopharmaceutical production for PET diagnostics; Radiographic equipment; Roentgenotherapeutic equipment; Linear accelerators; Gamma-therapy systems for distant and contact therapy. 17

Marketing

1IBCI Conference overview (1/2) Moscow, Russia 2012 The 1st International Business Conference for Suppliers, Producers and Consumers of Isotope Products (IBCI) 39 workshops Over 40 publications about the event Over 400 participants Over 80% isotope supplying countries were represented 19

1IBCI. Conference overview (2/2) UPCOMING MEETING September 30 October 1, 2013 The 2nd International Business Conference for Suppliers, Producers and Consumers of Isotope Products (IBCI) 20

Looking forward to future cooperation! Radiation Technologies Program Tel. +7 (499) 949-41-49 E-mail: MABatkov@rosatom.ru 21